NCS1 and prostate adenocarcinoma: According to the ICSDB database, NCS1 knockdown after CRISPR inhibited the proliferation of PRAD, PAAD, and GBM cell lines, providing a reference for subsequent cytological experiments to test the effect of NCS1 knockdown on tumor cell proliferation.